Literature DB >> 11106783

Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?

H H Schmid1.   

Abstract

Long-chain N-acylethanolamines (NAEs) and their precursors, N-acylethanolamine phospholipids, are ubiquitous trace constituents of animal and human cells, tissues and body fluids. Their cellular levels appear to be tightly regulated and they accumulate as the result of injury. Saturated and monounsaturated congeners which represent the vast majority of cellular NAEs can have cytoprotective effects while polyunsaturated NAEs, especially 20:4n-6 NAE (anandamide), elicit physiological effects by binding to and activating cannabinoid receptors. It is the purpose of this article to review published data on the pathways and mechanisms of NAE biosynthesis in mammals and to evaluate this information for its physiological significance. The generation and turnover of NAE via N-acyl PE through the transacylation-phosphodiesterase pathway may represent a novel cannabinoid receptor-independent signalling system, analogous to and possibly related to ceramide-mediated cell signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106783     DOI: 10.1016/s0009-3084(00)00188-2

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  41 in total

Review 1.  New approaches and challenges to targeting the endocannabinoid system.

Authors:  Vincenzo Di Marzo
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

2.  Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.

Authors:  Pouya Movahed; Vladimir Evilevitch; Tomas L G Andersson; Bo A G Jönsson; Per Wollmer; Peter M Zygmunt; Edward D Högestätt
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 3.  Cellular accumulation of anandamide: consensus and controversy.

Authors:  Cecilia J Hillard; Abbas Jarrahian
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

4.  Endocannabinoid system acts as a regulator of immune homeostasis in the gut.

Authors:  Nandini Acharya; Sasi Penukonda; Tatiana Shcheglova; Adam T Hagymasi; Sreyashi Basu; Pramod K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

5.  Bile Acid Recognition by NAPE-PLD.

Authors:  Eleonora Margheritis; Beatrice Castellani; Paola Magotti; Sara Peruzzi; Elisa Romeo; Francesca Natali; Serena Mostarda; Antimo Gioiello; Daniele Piomelli; Gianpiero Garau
Journal:  ACS Chem Biol       Date:  2016-09-12       Impact factor: 5.100

6.  Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure.

Authors:  Birthe Moesgaard; Henrik H Hansen; Suzanne L Hansen; Steen Honore Hansen; Gitte Petersen; Harald S Hansen
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

7.  N-acylethanolamines are metabolized by lipoxygenase and amidohydrolase in competing pathways during cottonseed imbibition.

Authors:  Rhidaya Shrestha; Minke A Noordermeer; Marcelis van der Stelt; Gerrit A Veldink; Kent D Chapman
Journal:  Plant Physiol       Date:  2002-09       Impact factor: 8.340

Review 8.  Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.

Authors:  Renato Malcher-Lopes; Alier Franco; Jeffrey G Tasker
Journal:  Eur J Pharmacol       Date:  2008-01-31       Impact factor: 4.432

Review 9.  Pharmacology of traumatic brain injury: where is the "golden bullet"?

Authors:  Kathryn Beauchamp; Haitham Mutlak; Wade R Smith; Esther Shohami; Philip F Stahel
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.